World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
67
Citations
21528
World Ranking
2239
National Ranking
32

Lars Østergaard publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Lars Østergaard sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 312 publications — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Lars Østergaard D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Lars Østergaard sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 67 D-Index — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Lars Østergaard is affiliated with Aarhus University Hospital in Denmark and has contributed extensively to the field of medicine, with a focus on infectious diseases, neurology, epidemiology, molecular biology, and immunology. Their research encompasses a broad spectrum of studies centered primarily on infectious diseases and related clinical research.

The main topics of their work include:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Long-Term Effects of COVID-19
  • COVID-19 and Mental Health
  • HIV Research and Treatment
  • SARS-CoV-2 detection and testing
  • HIV/AIDS Research and Interventions

Østergaard has frequently published in the following venues:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • SSRN Electronic Journal
  • International Journal of Infectious Diseases
  • EBioMedicine
  • Clinical Neurophysiology

Their recent publications include:

  • Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial, 2020, The Lancet Oncology
  • A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19, 2020, New England Journal of Medicine
  • Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial., 2021, EClinicalMedicine
  • SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses, 2021, EBioMedicine
  • Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial, 2022, Nature Medicine

The scientist has collaborated extensively with several coauthors, including:

  • Martin Tolstrup
  • Işık Somuncu Johansen
  • Ole S. Søgaard
  • Thomas Benfield
  • Christian Erikstrup

With 194 publications in medicine and significant contributions in infectious diseases (87 publications) and neurology (26 publications), Østergaard's work displays strong interdisciplinary engagement across epidemiology, molecular biology, and immunology. The breadth of study topics highlights involvement in ongoing research related to emerging infectious diseases and their long-term impacts.

Best Publications

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

    Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka

  • Maternal Infection Requiring Hospitalization During Pregnancy and Autism Spectrum Disorders

    Hjördis Ó. Atladóttir;Poul Thorsen;Lars Østergaard;Diana E. Schendel

  • Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

    Alison J Rodger;Valentina Cambiano;Tina Bruun;Pietro Vernazza

  • Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial

    Thomas A Rasmussen;Martin Tolstrup;Christel R Brinkmann;Rikke Olesen

  • The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo.

    Ole S. Søgaard;Mette E. Graversen;Steffen Leth;Rikke Olesen

  • Systematic review: noninvasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae.

    Robert L. Cook;Shari L. Hutchison;Lars Østergaard;R. Scott Braithwaite

  • Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis

    Jonathan Z. Li;Roger Paredes;Heather J. Ribaudo;Evguenia S. Svarovskaia

  • A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.

    Jens D Lundgren;Birgit Grund;Christina E Barkauskas;Thomas L Holland

  • IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication

    Martin R. Jakobsen;Rasmus O. Bak;Annika Andersen;Randi K. Berg;Randi K. Berg

  • Comparison of HDAC inhibitors in clinical development: effect on HIV production in latently infected cells and T-cell activation.

    Thomas Aagaard Rasmussen;Ole Schmeltz Sogaard;Christel Brinkmann;Fiona Wightman

  • Live Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis activate the inflammatory response through Toll-like receptors 2, 4, and 9 in species-specific patterns

    Trine H. Mogensen;Søren R. Paludan;Mogens Kilian;Lars Østergaard

  • Home Sampling versus Conventional Swab Sampling for Screening of Chlamydia trachomatis in Women: A Cluster-Randomized 1-Year Follow-up Study

    Lars Østergaard;Berit Andersen;Jens K. Møller;Frede Olesen

  • DC-SIGN (CD209), pentraxin 3 and vitamin D receptor gene variants associate with pulmonary tuberculosis risk in West Africans.

    R Olesen;C Wejse;C Wejse;D R Velez;C Bisseye

  • Combined effect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B/2A trial

    Steffen Leth;Steffen Leth;Mariane H Schleimann;Mariane H Schleimann;Sara K Nissen;Sara K Nissen;Jesper F Højen;Jesper F Højen

  • Randomized double-blind controlled trial of roxithromycin for prevention of abdominal aortic aneurysm expansion.

    S. Vammen;J. S. Lindholt;L. Østergaard;H. Fasting

  • Functional IRF3 deficiency in a patient with herpes simplex encephalitis

    Line Lykke Andersen;Nanna Mørk;Line S. Reinert;Emil Kofod-Olsen

  • Mycoplasma genitalium: prevalence and behavioural risk factors in the general population

    Berit Andersen;Ineta Sokolowski;Lars Østergaard;Jens Kjølseth Møller

  • Genomic HIV RNA Induces Innate Immune Responses through RIG-I-Dependent Sensing of Secondary-Structured RNA

    Randi K. Berg;Jesper Melchjorsen;Johanna Rintahaka;Elisabeth Diget

  • Early Innate Recognition of Herpes Simplex Virus in Human Primary Macrophages Is Mediated via the MDA5/MAVS-Dependent and MDA5/MAVS/RNA Polymerase III-Independent Pathways

    Jesper Melchjorsen;Johanna Rintahaka;Stine Søby;Kristy A. Horan

  • Population-Based Strategies for Outreach Screening of Urogenital Chlamydia trachomatis Infections: A Randomized, Controlled Trial

    Berit Andersen;Frede Olesen;Jens K. Møller;Lars Østergaard

  • SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses.

    Line K. Vibholm;Stine S.F. Nielsen;Marie H. Pahus;Giacomo S. Frattari

  • Association of Hospitalization for Infection in Childhood With Diagnosis of Autism Spectrum Disorders: A Danish Cohort Study

    Hjördís Ósk Atladóttir;Poul Thorsen;Diana E. Schendel;Lars Østergaard

  • Improving the Immunogenicity of Pneumococcal Conjugate Vaccine in HIV-Infected Adults with a Toll-Like Receptor 9 Agonist Adjuvant: A Randomized, Controlled Trial

    Ole S Søgaard;Nicolai Lohse;Zitta B Harboe;Rasmus Offersen

Frequent Co-Authors

Trine H. Mogensen
Trine H. Mogensen Aarhus University
Søren R. Paludan
Søren R. Paludan Aarhus University
Lars Bo Andersen
Lars Bo Andersen University of Bergen
Peter Aaby
Peter Aaby University of Southern Denmark
Jan Gerstoft
Jan Gerstoft Rigshospitalet
Svend Birkelund
Svend Birkelund Aalborg University
Henrik Toft Sørensen
Henrik Toft Sørensen Aarhus University
Gunna Christiansen
Gunna Christiansen Aalborg University
Thomas Benfield
Thomas Benfield Copenhagen University Hospital
Mathias Lichterfeld
Mathias Lichterfeld Brigham and Women's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students studying Microbiology in the USA, exploring related online degrees can open diverse career opportunities. One practical option is to pursue a fast track medical billing and coding certificate online. This credential allows graduates to enter the healthcare industry quickly with specialized administrative skills that complement a science background.

Additionally, if you are interested in expanding your clinical knowledge without relocating, many medical degrees online provide flexible pathways into healthcare professions. These programs include options from nursing to public health, which often intersect with microbiology in areas like infectious disease management.

Public health is another promising avenue. Students might consider some of the easiest MPH online programs to get into, offering accessible routes to careers focused on community health and epidemic control. Such degrees blend microbiological insights with population health strategies.

For those intrigued by patient-centered roles, becoming a child life specialist could be rewarding. Learning about how much do child life specialists make and the career requirements can help microbiology graduates assess this meaningful career path in pediatric healthcare support.

Best Scientists Citing Lars Østergaard

Trending Scientists

Recently Published Articles